These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7196236)

  • 1. A pilot study to evaluate the effect of acute and long-term administration of cyclandelate on the vigilance of subjects submitted to hypoxic conditions. Preliminary report.
    Schaffler K; Hörmann E; Arnold H
    Arzneimittelforschung; 1981; 31(6):1032-5. PubMed ID: 7196236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-hypoxaemic effect of cyclandelate in man measured in human volunteers using computer-assisted oculodynamic methodology.
    Schaffler K
    Br J Clin Pract Suppl; 1984; 34():51-7. PubMed ID: 6430324
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of cyclandelate on the CNS--a double-blind, placebo-controlled study of healthy subjects].
    Dimpfel W; Netter P; Spüler M; Wedekind W
    Klin Wochenschr; 1991 May; 69(7):313-9. PubMed ID: 2067317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of cyclandelate in the treatment of disorders of ageing.
    Le Poncin-Lafitte M
    Br J Clin Pract Suppl; 1984; 34():58-61. PubMed ID: 6430325
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative effect of cyclandelate and papaverine on the cerebral circulation of the rabbit].
    Dumery JP
    Nouv Presse Med; 1976 Oct; 5(32):2081. PubMed ID: 980735
    [No Abstract]   [Full Text] [Related]  

  • 6. The inhibition of hepatic S-3-hydroxy-3-methylglutaryl-CoA reductase by 3,3,5-trimethylcyclohexanol and its mandelic acid ester, cyclandelate.
    Middleton B; Middleton A; Miciak A; White DA; Bell GD
    Biochem Pharmacol; 1983 Feb; 32(4):649-51. PubMed ID: 6681959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double blind study of the hypoxia protective effect of a standardized Ginkgo biloba preparation after repeated administration in healthy subjects].
    Schaffler K; Reeh PW
    Arzneimittelforschung; 1985; 35(8):1283-6. PubMed ID: 3907639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium modulation and clinical effect. Profile of cyclandelate.
    Timmerman H
    Drugs; 1987; 33 Suppl 2():1-4. PubMed ID: 3622303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human platelet aggregation by cyclandelate.
    Van den Hoven WE; Hall DW
    Br J Clin Pract Suppl; 1984; 34():34-8. PubMed ID: 6430321
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation into 3.5.5-trimethylcyclohexyl mandelate (cyclospasmol).
    EIJKEL G; ERNSTING MJ; REKKER RF; NAUTA WT
    Pharm Weekbl; 1956 Feb; 91(3):81-90. PubMed ID: 13310218
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of cyclandelate vaso-active properties by the measure of the ear-retina time in the rabbit (author's transl)].
    Andermann C; Andermann G; Ehinger C
    Ann Pharm Fr; 1980; 38(3):253-60. PubMed ID: 7425477
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute effects of two dosages of orally administered midazolam on psychomotor performance in healthy volunteers.
    Schaffler K; Klausnitzer W
    Arzneimittelforschung; 1989 Mar; 39(3):395-8. PubMed ID: 2757665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of early diabetic retinopathy with cyclandelate.
    Cunha-Vaz JG; Reis Fonseca J; Hagenouw JR
    Br J Ophthalmol; 1977 Jun; 61(6):399-404. PubMed ID: 326306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclandelate: calcium modulation and clinical effects. Proceedings of a symposium. Helsinki, 14-15 November, 1986.
    Drugs; 1987; 33 Suppl 2():1-141. PubMed ID: 3622302
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of cyclandelate on cholesterol synthesis.
    Middleton B; Middleton A; Miciak A; Edwards E; Whitten B; Bell GD; White DA
    Br J Clin Pract Suppl; 1984; 34():43-50. PubMed ID: 6430323
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclandelate and a number of its metabolites inhibit discocyte-echinocyte transformations of human erythrocytes.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():26-30. PubMed ID: 6430318
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclandelate in the treatment of senile mental changes: a double-blind evaluation.
    Rao DB; Georgiev EL; Paul PD; Guzman AB
    J Am Geriatr Soc; 1977 Dec; 25(12):548-51. PubMed ID: 336670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo inhibition of hepatic lipogenesis in the rat by cyclandelate (3,3',5-trimethylcyclohexanylmandelate).
    Middleton A; White DA; Bell GD; Middleton B
    Biochem Pharmacol; 1983 Oct; 32(20):3079-83. PubMed ID: 6639676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():31-3. PubMed ID: 6430320
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory action of cyclandelate and a number of its metabolites on cyclic AMP phosphodiesterase.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():20-5. PubMed ID: 6331483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.